U.S. Markets closed

CareFusion Intros ReVel Ventilator

Zacks Equity Research

CareFusion Corporation (NYSE: CFN - News), a worldwide medical technology company, recently unveiled a new transport ventilator to manage patients during transport. The portable device dubbed “ReVel” is geared for pediatric and adult patients requiring breathing support during transport.

The ReVel is CareFusion’s second palm top ventilator. The company, in December 2010, introduced the EnVe ventilator, the first in this category. Both these ventilators are engineered with the company’s proprietary “ActivCore” gas delivery system. The palm top ventilator technology offers high-end critical care ventilation and freedom from wall-air systems.

The ReVel ventilator, which complements the company’s alternate care offerings (includes emergency and military respiratory care), is designed to help physicians improve patient care, optimize ventilator therapy and cut costs. It has the ability to manage most critical and non-invasively ventilated patients from the point of emergency through the hospital, allowing potentially life-saving ventilation during transit.

Moreover, the new ventilator offers monitoring and clinical tools to help physicians better manage and care for patients. Its Spontaneous Breathing Trial (“SBT”) technology provides data which enables clinicians to safely detach patients from ventilation at the right time. The ReVel ventilator is also equipped with an integrated pulse oximeter for monitoring a patient's pulse rate and oxygen saturation level during transport.

The device weighs just 9.5 pounds compared with conventional systems which weigh more than 20 pounds. This light-weight device mounts easily in ground and air emergency vehicles including ambulances, helicopters and military aircraft.

California-based CareFusion is dedicated to facilitate hospitals improve safety and quality of care for patients. The company is a leader in dispensing technology. It offers products in the areas of surgical instruments, respiratory care, IV infusion, medication and supply dispensing as well as infection prevention.

CareFusion’s products include Alaris IV pumps as well as the Pyxis automated dispensing and patient identification system. The company competes with Baxter International (NYSE: BAX - News) and Becton, Dickinson and Company (NYSE: BDX - News), among others, in niche markets.

BECTON DICKINSON & CO (BDX): Read the Full Research ReportBAXTER INTL INC (BAX): Read the Full Research ReportZacks Investment Research